Fact CheckerSign in

NCT06284096Completed

The Personal Recovery Based Psychoeducation For Schizophrenia

Effect Of CHIME Based Group Psychoeducation On Personel Recovery In Individuals Diagnosed With Schizophrenia

Source: ClinicalTrials.gov · Last updated 17 Jun 2025

Brief summary (registry, in English)

This project aims to introduce a new psychoeducation program that helps individuals with schizophrenia to recover subjectively. The program's effectiveness will be evaluated through a randomized controlled research design. The goal is not only to emphasize clinical recovery but also to highlight the importance of individual recovery and promote its implementation. In this context, the following hypotheses have been formulated. Research Question: 1\) Does recovery-based psychoeducation have an impact on the subjective recovery level in individuals diagnosed with schizophrenia in remission? Hypotheses: H0a: Recovery-based psychoeducation does not affect the subjective recovery level in individuals diagnosed with schizophrenia in remission. H0b: Recovery-based psychoeducation does not effect on psychological resilience in individuals diagnosed with schizophrenia in remission. H0c: Recovery-based psychoeducation does not effect on hope in individuals diagnosed with schizophrenia in remission. H1a: Recovery-based psychoeducation affects the subjective recovery level in individuals diagnosed with schizophrenia in remission. H1b: Recovery-based psychoeducation has an effect on psychological resilience in individuals diagnosed with schizophrenia in remission. H1c: Recovery-based psychoeducation has an effect on hope in individuals diagnosed with schizophrenia in remission.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
21 Feb 2024
Start date
1 Jan 2024
Primary completion date
23 Feb 2024
Lead sponsor
Istanbul University - Cerrahpasa
NCT number
NCT06284096

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jan 2024 to the primary completion date, 23 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of alcohol or substance abuse (excluding nicotine),
  • Presence of comorbid neurocognitive disorders.

Who the study is looking for

  • Diagnosis of schizophrenia,
  • Age between 18 and 65,
  • Willingness to participate in the study,
  • At least 6 months in remission,
  • Literacy,
  • No hearing or comprehension problems.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Umraniye Community Mental Health Center affiliated with the Ministry of Health.
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.